Uremic toxins: some thoughts on acrolein and spermine

Kunal K Sindhu1

  • 1a Warren Alpert School of Medicine at Brown University , Providence , RI , USA.

Renal Failure
|October 21, 2016
PubMed

Insights

Uremic toxins contribute to cardiovascular risks in chronic kidney disease (CKD). Recent findings suggest acrolein, not spermine, is the primary toxin responsible for these adverse effects in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Toxicology

Background:

  • Chronic kidney disease (CKD) involves reduced glomerular filtration and uremic toxin accumulation.
  • CKD patients face elevated cardiovascular mortality risk, inadequately explained by traditional risk factors.
  • Uremic toxins are implicated as a key factor in CKD-related cardiovascular complications.

Purpose of the Study:

  • To review recent literature on the role of spermine and its derivatives as uremic toxins.
  • To clarify the specific uremic toxin responsible for cardiovascular risks in CKD.
  • To re-evaluate the hypothesis of spermine as a significant uremic toxin.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies investigating uremic toxins and cardiovascular outcomes in CKD.
  • Examination of the metabolic pathways and toxicological profiles of spermine and acrolein.

Main Results:

  • Evidence casts doubt on spermine's role as a primary uremic toxin.
  • Acrolein, an oxidative product of spermine and spermidine, is identified as a likely uremic toxin.
  • Acrolein may account for toxic effects previously attributed to spermine.

Conclusions:

  • Acrolein, rather than spermine, is likely responsible for the cardiovascular toxicity associated with uremic toxins in CKD.
  • This finding necessitates a re-evaluation of therapeutic strategies targeting uremic toxins in chronic kidney disease management.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.9K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
1.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.4K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.3K